Detalhe da pesquisa
1.
NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.
J Immunol
; 188(10): 4940-50, 2012 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22490867
2.
FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models.
Sci Rep
; 14(1): 787, 2024 01 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38191799
3.
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.
Cancers (Basel)
; 15(23)2023 Dec 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38067396
4.
Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis.
NPJ Syst Biol Appl
; 9(1): 61, 2023 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38086828
5.
Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential.
Cancers (Basel)
; 15(16)2023 Aug 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37627155
6.
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.
Front Immunol
; 14: 1295208, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38235131
7.
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer.
Commun Biol
; 6(1): 1152, 2023 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37957414
8.
The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.
Cancer Res Commun
; 2(6): 417-433, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36311166
9.
The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy.
Cancers (Basel)
; 10(8)2018 Jul 24.
Artigo
Inglês
| MEDLINE | ID: mdl-30042343
10.
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.
Cancers (Basel)
; 10(8)2018 Jul 26.
Artigo
Inglês
| MEDLINE | ID: mdl-30049987
11.
NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes.
Oncoimmunology
; 5(6): e1151593, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27471621